Please login to the form below

Not currently logged in
Email:
Password:

GSK announces combination approval for Avodart

GlaxoSmithKline has announced that the US Food and Drug Administration has approved Avodart in combination with tamsulosin (Flomax) for the treatment of symptomatic enlarged prostate
GlaxoSmithKline (GSK) has announced that the US Food and Drug Administration (FDA) has approved Avodart in combination with tamsulosin (Flomax) for the treatment of symptomatic enlarged prostate.

Half of all men over 50 years old are affected by enlarged prostate. The two-year study into the use of Avodart combined with tamsulosin showed that in combination the medicines were more effective than single drug therapies at treating common symptoms such as nocturia.

Both drugs already have FDA approval for use singularly in the treatment of enlarged prostate. "The combination of Avodart and tamsulosin at diagnosis allows doctors to simultaneously treat the patient's prostate on two fronts by reducing prostate size and rapidly improving symptoms," said Dr Steven A Kaplan, from Weill Cornell Medical College of Cornell University in New York City.

The randomised, double-blind study of the combination of Avodart and tamsulosin is one of the largest clinical trials to date involving men with enlarged prostate. It was the first long term assessment of the combination of Avodart, which works by suppressing the male hormone responsible for the enlargement of the prostate, and an alpha-blocker.

23rd June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....
Personas: a top tool for personalising pharma marketing campaigns
Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively....

Infographics